| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |